The Extraneuronal Transporter for Monoamine Transmitters Exists in Cells Derived from Human Central Nervous System Glia

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Neuroscience

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1460-9568.1996.tb01294.xPMID 8752596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of L-glutamate uptake into and release from astrocytes and neurons cultured from different brain regions

  2004cited by this paper
• The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process

  1997cited by this paper
• THE UPTAKE OF CATECHOL AMINES AT HIGH PERFUSION CONCENTRATIONS IN THE RAT ISOLATED HEART: A NOVEL CATECHOL AMINE UPTAKE PROCESS

  1997cited by this paper
• Extraneuronal transport of noradrenaline.

  1994cited by this paper
• Comparison of two new inhibitors of catechol O‐methylation on striatal dopamine metabolism: a microdialysis study in rats

  1994cited by this paper
• Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection, and biological activity.

  1993cited by this paper
• Symptomatic anti-parkinsonian effects of monoamine oxidase-B inhibition: comparison of selegiline and lazabemide.

  1993cited by this paper
• Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport

  1993cited by this paper
• Clinical pharmacology of the new COMT inhibitor CGP 28 014

  1993cited by this paper
• Symptomatic anti-parkinsonian effects of monoamine oxidase-B inhibition: comparison of selegiline and lazabemide.

  1993cited by this paper
• Plasticity of Astroglial Glutamate and γ‐Aminobutyric Acid Uptake in Cell Cultures Derived from Postnatal Mouse Cerebellum

  1993cited by this paper
• The influence of the density of adrenergic innervation on the extracellular steady-state concentration gradient for 3H-noradrenaline

  1992cited by this paper
• Transporter explosion: update on uptake.

  1992cited by this paper
• The force driving the extraneuronal transport mechanism for catecholamines (uptake2)

  1992cited by this paper
• The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+)

  1992cited by this paper
• Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells)

  1990cited by this paper
• Astrocytes as a primary locus for the conversion MPTP into MPP+

  1989cited by this paper
• Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

  1989cited by this paper
• Sodium‐independent transport of noradrenaline in mouse and rat astrocytes in primary culture

  1989cited by this paper
• Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem.

  1988cited by this paper
• The Extraneuronal Uptake and Metabolism of Catecholamines

  1988cited by this paper
• Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier

  1988cited by this paper
• The uptake and O-methylation of 3H-(±)-isoprenaline in rat cerebral cortex slices

  1988cited by this paper
• Regional Differences in 5‐Hydroxytryptamine and Catecholamine Uptake in Primary Astrocyte Cultures

  1986cited by this paper
• Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes.

  1986cited by this paper
• Amino acid and monoamine transport in primary astroglial cultures from defined brain regions

  1985cited by this paper
• Transport of monoamine and amino acid neurotransmitters by primary astroglial cultures

  1985cited by this paper
• Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study

  1985cited by this paper
• The outward transport of catecholamines mediated by uptake2 of the rat heart

  1985cited by this paper
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

  1984cited by this paper
• The substrate specificity of uptake 2 in the rat heart

  1984cited by this paper
• High‐Affinity Uptake of [3H]Norepinephrine by Primary Astrocyte Cultures and Its Inhibition by Tricyclic Antidepressants

  1983cited by this paper
• Cerebellar astroglial cells in primary culture: expression of different morphological appearances and different ability to take up [3H]D-aspartate and [3H]GABA.

  1983cited by this paper
• Chemosensitivity of malignant human brain tumors

  1983cited by this paper
• Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.

  1982cited by this paper
• Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.

  1982cited by this paper
• Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture.

  1981cited by this paper
• Immunohistochemical demonstration of catechol-o-methyltransferase in mammalian brain.

  1979cited by this paper
• Tricyclic antidepressants.

  1979cited by this paper
• Tricyclic antidepressants (first of two parts).

  1978cited by this paper
• The fine structure of the nervous system: The neurons and supporting cells

  1976cited by this paper
• The kinetics of enzyme action and inhibition in intact tissues and tissue slices, with special reference to cholinesterase

  1976cited by this paper
• Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems

  1975cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine.

  1970cited by this paper
• Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart.

  1970cited by this paper
• Inhibition of catecholamine Uptake2 by steroids in the isolated rat heart

  1970cited by this paper
• The extraneuronal uptake and localization of noradrenaline in the cat spleen and the effect on this of some drugs, of cold and of denervation

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Insights on the Correlation between Mitochondrial Dysfunction and the Progression of Parkinson's Disease.

  2023cites this paper
• Organic Cation Transporter Expression and Function in the CNS.

  2021cites this paper
• Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications.

  2021cites this paper
• Comparative analysis of novel decynium‐22 analogs to inhibit transport by the low‐affinity, high‐capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter

  2019cites this paper
• Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta

  2019cites this paper
• Glial and neuroinflammatory targets for treating substance use disorders.

  2017cites this paper
• Etude des mécanismes cellulaires et moléculaires impliqués dans les effets neuroprotecteurs du gliopeptide OctaDecaNeuropeptide (ODN) dans un model murin de la Maladie de Parkinson

  2017cites this paper
• Do Astrocytes Respond to Dopamine ? Do Astrocytes Respond to Dopamine ?

  2016cites this paper
• Organic Cation Transporters

  2016cites this paper
• Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A (13)C NMR study.

  2016cites this paper
• Exploring the concept of human OCT3 inhibitors as a novel class of antidepressants

  2016cites this paper
• Morphogenic Effects Of Dopamine In Cultured Rat Hippocampal Astrocytes

  2016cites this paper
• Do Astrocytes Respond To Dopamine

  2016cites this paper
• Organic Cation Transporters (OCTs) as Modulators of Behavior and Mood

  2016cites this paper
• Organic Cation Transporters as Modulators of Neurodegeneration and Neuroprotection in the Brain

  2016cites this paper
• From Man to Mouse: The MPTP Model of Parkinson Disease

  2015cites this paper
• Role of organic cation transporters (OCTs) in the brain.

  2015cites this paper
• Systems Regulating and Inducing Dopaminergic Cell Death in Parkinson’s Disease: an Analysis of Signalling Associated with Parkinson's Disease Models

  2015cites this paper
• uptake in rat brain cortex: contribution of glial cells Purinergic modulation of norepinephrine release and

  2015cites this paper
• Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.

  2014cites this paper
• Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma‐derived cell line

  2014influential citation
• Organic cation transporter variation and response to smoking cessation therapies.

  2014cites this paper
• miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway

  2014cites this paper
• Glioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP+ substrate to the nuclei.

  2014cites this paper
• Modulation Of CNS Neurotransmitter Levels And Associated Behaviors In Organic Anion Transporter 1 (Slc22a6) And Organic Anion Transporter 3 (Slc22a8) Knockout Mice

  2014cites this paper
• Vulnérabilité des neurones dopaminergiques dans la maladie de Parkinson : rôle des afférences excitatrices des systèmes cholinergique pédonculopontin et orexinergique hypothalamique

  2014cites this paper
• Purinergic modulation of norepinephrine release and uptake in rat brain cortex: contribution of glial cells.

  2013cites this paper
• Visualization of implanted GL261 glioma cells in living mouse brain slices using fluorescent 4-(4-(dimethylamino)-styryl)-N-methylpyridinium iodide (ASP+).

  2012cites this paper
• Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.

  2011cites this paper
• The contribution of low‐affinity transport mechanisms to serotonin clearance in synaptosomes

  2011cites this paper
• Environmental Exposure, Obesity, and Parkinson’s Disease: Lessons from Fat and Old Worms

  2010cites this paper
• Renal Organic Cation and Anion Transport: From Physiology to Genes

  2010cites this paper
• Decreased anxiety in mice lacking the organic cation transporter 3

  2009cites this paper
• Increased extracellular glutamate evoked by 1-Methyl-4-phenylpyridinium (MPP+) in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione

  2009cites this paper
• Chapter 8 The Impact of Astrocytes in the Clearance of Neurotransmitters by Uptake and Inactivation

  2009cites this paper
• Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics

  2009cites this paper
• MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters.

  2009cites this paper
• Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression.

  2009cites this paper
• Distribution of organic cation transporter 3, a corticosterone‐sensitive monoamine transporter, in the rat brain

  2009influential citation
• Altered aminergic neurotransmission in the brain of organic cation transporter 3‐deficient mice

  2008influential citation
• Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.

  2008cites this paper
• Caki-1 Cells as a Model System for the Interaction of Renally Secreted Drugs with OCT3

  2008cites this paper
• The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.

  2008cites this paper
• Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).

  2008cites this paper
• Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP

  2008cites this paper
• THE ROLE OF DOPAMINE OXIDATION IN DOPAMINE-INDUCED TOXICITY, INITIATION OF ENDOPLASMIC RETICULUM STRESS, AND POTENTIATION OF ROTENONE-INDUCED TOXICITY IN DIFFERENTIATED PC12 CELLS

  2007cites this paper
• Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro

  2007cites this paper
• Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency.

  2006cites this paper
• Pesticides and Pesticide Mixtures Induce Neurotoxicity: Potentiation of Apoptosis and Oxidative Stress

  2006cites this paper
• Histamine transport in neonatal and adult astrocytes

  2006cites this paper
• The transport of organic cations in the small intestine: Current knowledge and emerging concepts

  2006cites this paper
• Modifications neurochimiques au sein des ganglions de la base et comportements moteurs associés lors d'une stimulation électrique du noyau subthalamique chez le rat hémiparkinsonien ou de la mise en place de la dénervation dopaminergique chez le singe

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Corticosterone-Sensitive Monoamine Transport in the Rat Dorsomedial Hypothalamus: Potential Role for Organic Cation Transporter 3 in Stress-Induced Modulation of Monoaminergic Neurotransmission

  2006influential citation
• Differential modulation of anterior cingulate cortical activity by afferents from ventral tegmental area and mediodorsal thalamus

  2005cites this paper
• Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice.

  2005cites this paper
• Effect of 1-methyl-4-phenylpyridinium (MPP+) on mitochondrial membrane potential in cerebellar neurons: Interaction with the NMDA receptor

  2005cites this paper
• Corticosterone modulates noradrenaline‐induced melatonin synthesis through inhibition of nuclear factor kappa B

  2005cites this paper
• The MPTP model of Parkinson's disease.

  2005cites this paper
• Caenorhabditis elegans MPP+ Model of Parkinson’s Disease for High-Throughput Drug Screenings

  2004cites this paper
• Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration

  2004cites this paper
• Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation

  2004cites this paper
• Antitumor Efficacy of SarCNU in a Human Glioma Xenograft Model Expressing Both MGMT and Extraneuronal Monoamine Transporter

  2004cites this paper
• Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.

  2004cites this paper
• Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders.

  2004cites this paper
• Structure-function relationship in P-type ATPases--a biophysical approach.

  2003cites this paper
• Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats.

  2003cites this paper
• Organic cation transporters.

  2003cites this paper
• Ectopic serotonin accumulation and efflux in rat mesencephalic slices after prior tissue 'radiolabelling'.

  2003cites this paper
• An update on the extraneuronal monoamine transporter (EMT): characteristics, distribution and regulation.

  2003cites this paper
• Uptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: comparison with 5-hydroxytryptamine.

  2003cites this paper
• Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)

  2003cites this paper
• The localisation of the extraneuronal monoamine transporter (EMT) in rat brain

  2003cites this paper
• Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes

  2002influential citation
• Regulation of [3H]MPP+ transport by phosphorylation/dephosphorylation pathways in RBE4 cells: role of ecto-alkaline phosphatase

  2002cites this paper
• Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells

  2002cites this paper
• Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines

  2002cites this paper
• Organic cation transporter mRNA and function in the rat superior cervical ganglion

  2002influential citation
• Modulation of uptake of organic cationic drugs in cultured human colon adenocarcinoma Caco‐2 cells by an ecto‐alkaline phosphatase activity

  2002cites this paper
• Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 inOrct3/Slc22a3-Deficient Mice

  2001cites this paper
• Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications.

  2001cites this paper
• Glutamate is not involved in the MPP+-induced dopamine overflow in the striatum of freely moving C57BL/6 mice

  2001influential citation
• Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2001cites this paper
• Release of amines from acidified stores following accumulation by Transport‐P

  2001cites this paper
• Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter.

  2001cites this paper
• Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems

  2001cites this paper
• α1B adrenergic receptors in gonadotrophin‐releasing hormone neurones: relation to Transport‐P

  2001cites this paper
• Neurochemical findings in the MPTP model of Parkinson's disease

  2001cites this paper
• Involvement of noradrenaline transporters in S-nitrosocysteine-stimulated noradrenaline release from rat brain slices: existence of functional Na(+)-independent transporter activity.

  2001cites this paper
• Deficient Mice Orct 3 / Slc 22 a 3-Uptake-2 in Monoamine Transporter System Known as Impaired Activity of the Extraneuronal

  2001cites this paper
• Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells

  2000cites this paper
• Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder.

  2000cites this paper
• Transport of [3H]MPP+ in an immortalized rat brain microvessel endothelial cell line (RBE 4)

  2000cites this paper
• Analysis of the gene structure of the human (SLC22A3) and murine (Slc22a3) extraneuronal monoamine transporter

  2000cites this paper
• Gene structures of the human non-neuronal monoamine transporters EMT and OCT2

  2000cites this paper
• Antitumor effect of sarcnu in a 06-methylguanine-DNA methyltransferase positive human glioma xenograft model

  2000cites this paper
• Regulation of dopamine uptake by basic fibroblast growth factor and epidermal growth factor in cultured rat astrocytes.

  1999cites this paper
• Pharmacological characterization of dopamine transport in cultured rat astrocytes.

  1999cites this paper
• Enhanced Antitumor Activity of SarCNU in Comparison to BCNU in an Extraneuronal Monoamine Transporter Positive Human Glioma Xenograft Model

  1999cites this paper
• Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone

  1999cites this paper